DAIR procedure: Definition, Uses, and Clinical Overview

Posted on February 28, 2026 | by drknee

DAIR procedure Introduction (What it is)

DAIR procedure stands for Debridement, Antibiotics, and Implant Retention.
It is a treatment approach for certain infections involving a joint replacement, including knee replacements.
The goal is to control infection while keeping the existing implant in place.
It is most commonly discussed in the context of periprosthetic joint infection (PJI) after arthroplasty.

Why DAIR procedure used (Purpose / benefits)

The DAIR procedure is used when a bacterial infection is suspected or confirmed around a joint replacement, but the implant is still considered potentially retainable. In a knee replacement, infection can involve the tissues around the implant (soft tissue and synovium), the joint fluid, and the surfaces where bacteria can form a protective layer called a biofilm.

At a high level, DAIR aims to:

Reduce the infectious burden by surgically cleaning infected or inflamed tissue (debridement) and washing the joint.
Support infection control with antibiotics, typically guided by culture results (the specific antibiotic plan varies by clinician and case).
Preserve the prosthesis when removal is not clearly necessary or when early intervention may be effective.
Maintain function and mobility by avoiding or delaying more extensive revision surgery when appropriate.
Protect surrounding tissues by addressing infection before it causes further damage to bone, soft tissue, or the stability of the implant.

It is important to understand what DAIR is not: it is not a general knee pain procedure, and it is not used for arthritis management in a native (non-replaced) knee. It is a strategy most relevant to infected arthroplasty (joint replacement) cases.

Indications (When orthopedic clinicians use it)

Common scenarios where clinicians may consider the DAIR procedure include:

Early postoperative infection after knee arthroplasty, identified within a relatively short period after surgery (time thresholds vary by clinician and case).
Acute hematogenous infection, meaning a sudden infection that reaches the joint replacement through the bloodstream after the knee had been functioning well.
Stable implant components where imaging and intraoperative assessment suggest the fixed parts are not loose.
Good soft-tissue condition, where the skin and surgical wound can be closed and are likely to heal.
Symptoms consistent with acute infection, such as increasing pain, swelling, warmth, reduced range of motion, wound drainage, or fever (symptom patterns vary).
Diagnostic uncertainty with strong suspicion, where debridement and sampling may help clarify the cause while initiating treatment.

Contraindications / when it’s NOT ideal

DAIR procedure may be less suitable, or another approach may be preferred, in situations such as:

Implant loosening or mechanical failure (a loose prosthesis often requires revision rather than retention).
Chronic or long-standing infection, especially when bacteria have had time to mature a biofilm on implant surfaces (definitions of “chronic” vary by clinician and case).
Poor soft-tissue envelope, including compromised skin coverage, sinus tract (a chronic draining channel), or inability to achieve reliable wound closure.
Extensive bone loss or major tissue destruction suggesting infection has progressed beyond what debridement and retention can reasonably address.
Difficult-to-treat organisms or resistant infections, where the likelihood of controlling infection with retention may be lower (organism considerations vary by case and local protocols).
Medically high-risk situations where surgical risk outweighs potential benefit, or where infection control requires a different plan.
Recurrent infection after prior DAIR, where repeated retention strategies may be less favored (varies by clinician and case).

How it works (Mechanism / physiology)

Core principle: lowering bacterial load and disrupting infection niches

The DAIR procedure works by combining two key strategies:

Mechanical removal of infected tissue and debris (debridement) plus extensive irrigation (washing) of the joint space.
Biologic/chemical suppression of bacteria with systemic antibiotics, ideally selected based on cultures taken during the procedure.

A central challenge in joint replacement infection is biofilm—a structured community of bacteria that adheres to implant surfaces and can be less responsive to antibiotics alone. DAIR attempts to address this by physically clearing contaminated tissue and, in many approaches, exchanging modular parts (components designed to be removed without taking out the entire implant), which can reduce the amount of colonized material.

Relevant knee anatomy and structures (in the arthroplasty setting)

In an infected knee replacement, the focus is not on repairing ligaments or menisci (which may be partially resected or functionally altered during arthroplasty), but on managing infection within and around:

Femur and tibia bone interfaces with the implant (where fixation occurs).
Synovium and joint capsule, which can become inflamed and infected.
Extensor mechanism structures (quadriceps tendon, patella, patellar tendon), which are important for knee function and can be affected by swelling or soft-tissue compromise.
Joint space and fluid, which can harbor bacteria and inflammatory cells.
Modular components, often including a tibial polyethylene insert (in many total knee designs), which may be exchanged during DAIR depending on the case and implant system.

Onset, duration, and reversibility

Onset: DAIR is an operative intervention; any symptomatic improvement (such as decreased swelling or pain) depends on infection control and healing, which varies by clinician and case.
Duration: The procedure is a single event, but it is typically paired with a course of antibiotics and structured follow-up.
Reversibility: Because the implant is retained, DAIR is sometimes considered a “less extensive” surgical step than full implant removal, but it is not reversible in the sense of undoing surgery. If infection persists, further surgery (including revision) may still be required.

DAIR procedure Procedure overview (How it’s applied)

Below is a general workflow. Specific steps and sequencing vary by surgeon, institution, implant type, and infection presentation.

Evaluation and exam – Review of symptom timeline (pain, swelling, wound drainage, fevers). – Physical exam of the knee and incision, including warmth, effusion (fluid), range of motion, and stability.
Imaging and diagnostics – Blood tests that may reflect inflammation or infection (which tests are used varies). – Joint aspiration (sampling fluid from the knee) may be performed to assess cell counts and obtain cultures. – Imaging such as X-ray to evaluate implant position and signs that could suggest loosening (interpretation varies).
Preparation – Surgical planning based on suspected organism, implant design, and soft-tissue status. – Antibiotic timing is coordinated with culture strategy (protocols vary by clinician and case). – Anesthesia planning and medical optimization as appropriate.
Intervention (DAIR) – Surgical exposure of the joint (approach varies). – Debridement of infected/necrotic tissue and synovectomy as needed. – Irrigation to reduce contamination. – Collection of multiple tissue and fluid samples for culture. – Implant retention of fixed components; in many cases, exchange of modular components (for example, a polyethylene insert) is considered, depending on implant design and findings.
Immediate checks – Assessment of wound closure and soft-tissue viability. – Confirmation of stability and range of motion as appropriate for the surgical context. – Early postoperative monitoring for complications such as persistent drainage.
Follow-up and rehab – Antibiotic plan adjusted based on culture results and infectious disease guidance (team approach varies). – Monitoring of wound healing, symptoms, and lab trends over time. – Rehabilitation plan individualized to the knee status, soft tissues, and surgeon’s protocol, including guidance on weight-bearing and activity progression.

Types / variations

DAIR procedure is a concept with several practical variations. Common ways clinicians categorize or modify it include:

Timing-based categories
Early postoperative DAIR: used when infection is recognized soon after arthroplasty.
Acute hematogenous DAIR: used when infection appears abruptly later due to bloodstream spread.
Surgical approach
Open DAIR (arthrotomy): often used to allow thorough debridement and component assessment.
Arthroscopic washout: sometimes discussed for select cases, but its role can be limited in arthroplasty infection because implant interfaces and modular exchange may be harder to address arthroscopically (practice varies).
Component management
DAIR with modular component exchange: exchanging removable pieces (commonly the polyethylene liner in many total knee systems).
DAIR without exchange: may be considered in limited circumstances, though many protocols favor exchange when feasible (varies by clinician and case).
Adjunct strategies
Local antibiotic measures (such as antibiotic carriers) may be used in some settings; selection and evidence considerations vary by material and manufacturer, and by local practice.
Staged soft-tissue management when wound issues coexist, coordinated with plastic surgery in complex cases.

Pros and cons

Pros:

Preserves the existing implant, which can help maintain joint mechanics when successful.
Typically less reconstructive than full implant removal and revision.
Can reduce bacterial burden quickly by combining surgery with antibiotics.
Allows collection of multiple cultures to identify the organism and tailor antibiotics.
May shorten the pathway to functional recovery compared with revision in some scenarios (varies by clinician and case).
Can be an important option when patient factors make major revision surgery challenging.

Cons:

Infection may persist or recur, potentially requiring revision surgery later.
Biofilm on retained components can make eradication harder than in implant-removal strategies.
Requires surgery and anesthesia, with associated general operative risks.
Postoperative wound drainage or soft-tissue complications can occur in infected cases.
Antibiotic treatment can be prolonged and may cause side effects or interactions (specifics vary).
Outcomes depend heavily on timing, organism factors, implant stability, and tissue condition (varies by clinician and case).

Aftercare & longevity

Aftercare following DAIR procedure typically focuses on two parallel tracks: infection monitoring and knee function restoration. The exact plan differs by surgeon, infectious disease team involvement, and patient factors.

Key factors that can influence outcomes and durability include:

Time from symptom onset to intervention, as earlier treatment is often considered more favorable for retention strategies (definitions and thresholds vary).
Implant stability and alignment, since a mechanically failing implant may not tolerate retention.
Soft-tissue quality and wound healing, including whether the incision closes cleanly and remains dry.
Organism characteristics and antibiotic susceptibility, which influence antibiotic choices and expected response (varies by case and local resistance patterns).
Antibiotic adherence and monitoring, including lab surveillance and management of side effects (managed by the clinical team).
Rehabilitation participation and pacing, to restore range of motion, strength, and gait while respecting wound and tissue status (protocols vary).
Weight-bearing status and activity progression, which may be modified based on pain, swelling, soft-tissue condition, and surgeon preference.
Comorbidities that can affect healing and infection control, such as diabetes, smoking status, immune suppression, vascular disease, or malnutrition (impact varies).

“Longevity” after DAIR is not a single, predictable timeframe. Some patients maintain a functional implant for years after infection control, while others may need additional procedures. The course is individualized and depends on multiple interacting variables.

Alternatives / comparisons

Management of suspected or confirmed knee arthroplasty infection is typically individualized. DAIR procedure is one option among several, and the choice often depends on timing, implant stability, organism considerations, and soft-tissue status.

Common alternatives or related approaches include:

Observation/monitoring (limited role)
For a confirmed deep joint replacement infection, observation alone is generally not considered definitive treatment. However, monitoring may occur while diagnostic testing is underway or when suspicion is low and other causes of symptoms are being evaluated.
Antibiotics alone
Antibiotics without surgery may be considered in select nonoperative or suppressive strategies, particularly when surgery is not feasible. Antibiotics alone may be less effective when biofilm is established on implant surfaces (clinical decisions vary).
Repeat aspiration and diagnostic workup
If diagnosis is uncertain, clinicians may repeat joint aspiration, obtain additional labs, or assess other infection sources before choosing an operative plan.
One-stage revision (implant exchange in one operation)
Involves removing components and placing new ones in a single surgery, combined with debridement and antibiotics. Suitability depends on organism, soft tissue, and surgical factors (varies by clinician and case).
Two-stage revision
Often discussed as a standard strategy for chronic PJI in many settings: removal of components, placement of a spacer, antibiotic therapy, then later re-implantation. It is more extensive than DAIR and involves a longer treatment pathway.
Resection arthroplasty, arthrodesis (fusion), or amputation (rare, complex cases)
Considered in severe, recurrent, or limb-threatening infections, or when reconstruction is not viable. These are uncommon and highly individualized decisions.

Compared with revision strategies, DAIR procedure generally emphasizes retaining fixed implants while attempting to control infection. Compared with antibiotics alone, DAIR adds mechanical source control through debridement and sampling.

DAIR procedure Common questions (FAQ)

Q: Is the DAIR procedure the same as a “washout”?
DAIR procedure includes irrigation (“washout”), but it typically implies more than fluid rinsing alone. It also includes debridement of infected tissue, obtaining cultures, and using antibiotics as part of a coordinated plan. Many protocols also consider modular component exchange when feasible.

Q: What kind of anesthesia is used for DAIR procedure?
DAIR procedure is usually performed under anesthesia appropriate for an operative knee intervention, such as general or regional anesthesia. The choice depends on patient factors, surgical plan, and anesthesia team assessment. Specific approaches vary by clinician and case.

Q: How painful is recovery after DAIR procedure?
Pain experiences vary based on the severity of infection, the amount of inflamed tissue, and individual sensitivity. Postoperative discomfort is expected after surgical debridement, and swelling can also influence pain. Pain control plans are individualized by the treating team.

Q: How long do antibiotics last after DAIR procedure?
Antibiotic duration depends on the organism, culture results, clinical response, and local protocols. Treatment often involves an initial intensive phase and ongoing therapy guided by infectious disease principles. The exact length varies by clinician and case.

Q: Will the implant definitely be saved with DAIR procedure?
DAIR procedure is designed to try to control infection while retaining the implant, but success is not guaranteed. Persistent or recurrent infection may lead to additional surgery, including revision. Outcomes depend on timing, implant stability, organism factors, and soft-tissue status.

Q: How long until I can walk or bear weight after DAIR procedure?
Weight-bearing recommendations depend on the condition of the knee, soft tissues, implant stability, and the surgeon’s postoperative protocol. Some patients may be allowed to walk early with support, while others may have restrictions. The plan is individualized.

Q: When can someone drive or return to work after DAIR procedure?
Timing varies based on which knee was operated on, pain control, mobility, reaction time, and job demands. Driving also depends on whether narcotic pain medications are being used and functional control of the leg. Return-to-work planning is individualized and should be discussed with the treating team.

Q: Is DAIR procedure considered “safe”?
Any surgical procedure carries risks, and infection cases can add complexity. Common risk categories include anesthesia risks, wound issues, persistent infection, and blood clots, among others. The overall risk profile depends on patient health, infection severity, and surgical factors.

Q: What does DAIR procedure cost?
Costs vary widely by region, hospital system, insurance coverage, length of stay, antibiotic regimen, and whether additional procedures are required. Because DAIR is performed for infection, it may involve specialized care and follow-up that affect total cost. A hospital billing department or insurer typically provides the most case-specific estimates.

Q: What happens if DAIR procedure doesn’t control the infection?
If infection persists or returns, clinicians may reassess implant stability, culture results, antibiotic options, and soft-tissue condition. Next steps can include repeat debridement in select cases or moving to revision strategies such as one-stage or two-stage revision. The appropriate pathway varies by clinician and case.